The Role of Central Sensitization on Biopsychosocial Factors in Primary Sjögren's Syndrome
Exploring the Role of Central Sensitization on Biopsychosocial Factors in Primary Sjögren's Syndrome: a Cross-Sectional Analysis
1 other identifier
observational
100
1 country
1
Brief Summary
Following the guidance of individuals with primary Sjögren's Syndrome who receive diagnosis, routine medical care, and treatment management, the evaluations will be performed once by the researchers and will take approximately one hour. In addition, healthy individuals with a similar average age to the evaluation group without any disease diagnosis will be included in the study as a control group. Evaluations of the healthy group will be made once by the researchers and will take approximately one hour. Data will be collected face to face at the Faculty of Physical Therapy and Rehabilitation, Rheumatology Unit. Data collection tool of the research:
- Information about patients will be recorded with the Demographic Information Form.
- EULAR Sjögren's Syndrome Disease Activity Index
- EULAR Sjögren's Syndrome Patient Reporting Index
- Primary Sjögren's Syndrome Quality of Life Scale
- BETY-Biopsychosocial Questionnaire
- Central Sensitization Scale
- Pain Catastrophizing Scale
- Hospital Anxiety and Depression Scale
- Multidimensional Fatigue Rating Scale
- Turkish Eating Assessment Tool
- Yale Swallow Protocol
- Test of Mastication and Swallowing Solids
- Dysphagia Limit Test
- Xerostomia inventory
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 6, 2024
CompletedFirst Posted
Study publicly available on registry
May 13, 2024
CompletedStudy Start
First participant enrolled
June 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedFebruary 28, 2025
December 1, 2024
6 months
May 6, 2024
February 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
BETY-Biopsychosocial Questionnaire (BETY-BQ)
BETY-BQ consists of the following six subtitles that investigate in detail the biopsychosocial dimensions: pain, functionality and fatigue, mood, sociability, sexuality, and sleep quality. This scale consists of 30 items, scored on a 5-point Likert system. Each question is scored as "No never: 0 Yes rarely: 1 Yes sometimes: 2 Yes often: 3 Yes always: 4" and a total score over 30 items. A higher score indicates a poorer biopsychosocial situation.
baseline
Turkish Eating Assessment Tool
Turkish Eating Assessment Tool is a survey consisting of 10 questions with a Likert scale between 0 and 4 (0 = no problem, 4 = severe problem). The total score is calculated out of 40 points by finding the sum of the answers given by individuals to each question. A score of 3 or more in the survey is considered abnormal. A score of 16 or above is considered as suspicion of aspiration.
baseline
Xerostomia inventory
The scale consists of 11 items. Patients will be asked to choose the best response for each item describing their symptoms over the previous two weeks. Responses are scored from 1 to 5 (1: never, 2: rarely, 3: occasionally, 4: fairly often, and 5: very often). The sum of the item scores gives a total score ranging from 11 to 55, and a higher score indicates that the symptoms are more severe.
baseline
Multidimensional Fatigue Rating Scale
This scale evaluates fatigue with 16 items under 5 subheadings: degree, severity, impact on daily activities, troubles it causes, and fatigue time. The score ranges from 0 (not tired) to 50 (extremely tired).
baseline
Hospital Anxiety and Depression Scale (HADS)
In this scale consisting of fourteen questions, odd-numbered questions questioning anxiety, and even questions question depression. Options range from 0 to 3, with a higher score indicating a poor emotional state. The cut-off values of the scale were determined as 10 for the anxiety subscale and 7 for the depression subscale.
baseline
Test of Mastication and Swallowing Solids
In our study, the Test of Masticating and Swallowing Solids (TOMASS) will be used. The test evaluates how many bites the individual takes to eat a biscuit while sitting upright, how many chewing cycles he makes, how many times he swallows it, and how long the total time is from biting to swallowing. Video recording will be taken during the test. The number of bites, number of chewing cycles, number of swallows and total time will be calculated on the video.
baseline
Dysphagia limit
While evaluating dysphagia, individuals are given 5, 10, 15, 20, 25, 30, 35, 40 and 45 mL volumes of liquid, respectively, with a graduated syringe and are asked to swallow the liquid. The maximum amount of fluid that the thyroid cartilage can swallow during a single movement is determined. The normal dysphagia limit in healthy individuals is more than 20 mL. If a person can swallow 20 mL normally, the dysphagia limit is normal.
baseline
Secondary Outcomes (6)
Central Sensitization Scale
baseline
Pain Catastrophizing Scale
baseline
EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI)
baseline
EULAR Sjögren's Syndrome Patient Reporting Index (ESSPRI)
baseline
Primary Sjögren's Syndrome Quality of Life Scale
baseline
- +1 more secondary outcomes
Study Arms (1)
Patients with primer Sjogren's syndrome
Eligibility Criteria
Individuals diagnosed with primary Sjögren's Syndrome according to the American European Consensus Criteria in Hacettepe University, Faculty of Medicine, Rheumatology Department, and volunteers to participate in the study will recruit this study. The total number of individuals to be included in the study will be calculated with 80% power and 95% confidence interval with the data obtained after the pilot study.
You may qualify if:
- Patients diagnosed with Primary Sjögren's Syndrome
- years or older
You may not qualify if:
- Patients with Secondary Sjögren's Syndrome,
- Patients who are diagnosed with other uncontrolled/clinically important diseases (chronic obstructive pulmonary disease, congestive heart failure, endocrine system diseases, neurological, psychological diseases, etc.),
- Having a malignant condition,
- Pregnant individuals in the third trimester,
- Individuals who do not agree to participate in the study and do not give written consent will be excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nazli Elif Nacar
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
May 6, 2024
First Posted
May 13, 2024
Study Start
June 19, 2024
Primary Completion
December 30, 2024
Study Completion
January 1, 2025
Last Updated
February 28, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share